MEngSc /PGDip (Pharmaceutical & Biopharmaceutical)
MEngSc/PG Dip in Pharmaceutical & Biopharmaceutical Engineering
The enormous need for Engineers to work in the pharmaceutical, biopharmaceutical and medical devices industries has been well documented in recent years, most recently by the Expert Group on Future Skills Needs: http://www.skillsireland.ie/Publications/2016/Biopharma-Skills-Report-FINAL-WEB-VERSION.pdf.
The MEngSc/PG Dip in Pharmaceutical & Biopharmaceutical Engineering are part time modularized degrees which can be taken over 24 months (for award of a Postgraduate Diploma) to 60 months. In undertaking these programmes participants will have the opportunity to gain formal educational qualification in areas of particular concern to the bio/pharmaceutical industry that they may not have benefitted from before, including issues such as product containment, powder/particle technology, design of API and secondary production facilities, current Good Manufacturing Practice (cGMP), design of classified facilities, aseptic processing facility design and validation.
To download the course brochure, please click here: MEngSc Flyer
The PG Diploma is identical to Part I of the MEngSc; both offer 60 ECTS credits on Pharmaceutical & Biopharmaceutical Engineering. The only difference between the two degrees is that the MEngSc involves an additional 30 credit minor thesis module to candidates who meet the required standards in Part I of the degree. Candidates of the MEngSc who choose not to proceed to Part II or who do not meet the required standards graduate with the PG Diploma.
MEngSc in Pharmaceutical & Biopharmaceutical Engineering (CKR35) (for more details, see here)
The aim of this (NQAI level 9) programme is to fill a need for the Continuing Professional Development and Postgraduate Education of Engineers working in the Pharmaceutical Industry. To date many Engineering graduates (including Chemical & Process Engineering graduates) do not have formal educational qualifications relating specifically to the pharmaceutical industry. This is because many undergraduate Chemical Engineering courses, which are generally broad in nature, do not cover issues of particular concern to the pharmaceutical industry; issues such as product containment, powder/particle technology, design of API and secondary production facilities, current Good Manufacturing Practice (cGMP), design of classified facilities, aseptic processing facility design, validation, etc. This is the case to an even greater extent the case for graduates of other Engineering disciplines.
PG Dip in Pharmaceutical & Biopharmaceutical Engineering (CKP08) (for more details, see here)
Many graduates working in the pharmaceutical industries with a scientific background find themselves working in areas which increasingly overlap with engineers and engineering. Many of them would like to develop an engineering based understanding of processes and production in a formal manner. This programme offers these graduates with significant benefits both to themselves and their companies by developing their skills set and employability across a wider range of roles through the enhanced continuing professional development that this programme offers. This programme also offers the pharmaceutical and biopharmaceutical industry with an opportunity to enable greater cohesion and understanding among inter and multi-disciplinary teams as graduates with science backgrounds receive a formal qualification in engineering.
Informal enquires are welcome and should be directed to Claire O'Sullivan or Dr Archishman Bose (see below).
Dr Archishman Bose
Process & Chemical Engineering, School of Engineering and Architecture, UCC
Tel: +353 21 490 3687